Related Articles
Toxicity, disease management and outcome of treatment with immune checkpoint inhibitors by sex in patients with cancer and preexisting autoimmune disease
Correlation between immune‑related adverse events and treatment efficacy of anti‑PD1 immunotherapy in patients with esophageal squamous cell carcinoma
Nivolumab‑induced cholangitis in patients with non‑small cell lung cancer: Case series and a review of literature
Factors associated with immune‑related severe adverse events (Review)
Myositis/myasthenia gravis caused by immune checkpoint inhibition: A report of two cases and a brief review of the literature